androstenediol has been researched along with trelstar in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belanger, A; Tremblay, Y | 1 |
| Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F | 1 |
2 other study(ies) available for androstenediol and trelstar
| Article | Year |
|---|---|
Changes in plasma steroid levels after single administration of hCG or LHRH agonist analogue in dog and rat.
Topics: 1-Methyl-3-isobutylxanthine; Androstenediol; Animals; Bucladesine; Chorionic Gonadotropin; Dehydroepiandrosterone; Dogs; Gonadotropin-Releasing Hormone; Male; Rats; Steroids; Testis; Testosterone; Time Factors; Triptorelin Pamoate | 1985 |
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1988 |